Table 1 Characteristics the KORA FF4 and LLS study participants
From: Epigenome-wide association study of dietary fatty acid intake
Characteristic | KORA FF4 (n = 1354) | LLS (n = 488) |
|---|---|---|
Age (years) | 58.8 (11.3) | 58.8 (6.3) |
Female | 718 (53.0%) | 258 (52.9%) |
BMI (kg/m2) | 27.6 (4.99) | 25.3 (3.4) |
Smoking | ||
Current | 200 (14.8%) | 61 (12.5%) |
Former | 587 (43.4%) | 275 (56.4%) |
Never | 567 (41.9%) | 152 (31.1%) |
Physical activity | ||
Active | 827 (61.1%) | – |
Non-active | 527 (38.9%) | – |
Energy intake (kcal) | 1851.9 (405.1) | 1992.8 (602.0) |
Current estrogen therapy | ||
Yes | 42 (5,8%) | – |
No | 676 (94.2%) | – |
PUFA supplement intake | ||
Yes | 33 (2.4%) | – |
No | 1321 (97.6%) | – |
PUFA n-3 intake (mg/day) | ||
ALA | 1069.88 (311.81) | 1045.30 (622.18) |
SDA | 41.99 (27.25) | – |
EPA | 147.06 (82.40) | 77.32 (68.19) |
DPA | 56.43 (16.31) | – |
DHA | 203.31 (86.78) | 125.92 (108.10) |
PUFA n-6 intake (mg/day) | ||
LA | 8259.37 (2232.79) | 13,307.00 (6530.12) |
EDA | 46.61 (21.24) | – |
ARA | 195.34 (56.33) | – |